DWI-FLAIR mismatch versus perfusion-based selection for extended window thrombolysis in acute ischemic stroke: a meta-analysis of randomized controlled trials

Несоответствие DWI–FLAIR по сравнению с отбором на основе перфузии для тромболитической терапии в расширенном временном окне при остром ишемическом инсульте: метаанализ рандомизированных контролируемых исследований
Jagkirat Singh, Victor Hugo Pinheiro Lopes, Marianna Gerardo Hidalgo Santos Jorge Leite, Gustavo Nascimento de Medeiros, Julie de Lima Loiola, Luisa Medeiros Visentini, Ocílio Ribeiro Gonçalves, Amit Bansal, Leonardo Di Cosmo
2026-09-18

DWI-FLAIR mismatchacute ischemic strokeextended-window thrombolysisperfusion-based selectionsymptomatic intracranial hemorrhage
To compare efficacy and safety outcomes of DWI–FLAIR mismatch versus CT/MR perfusion-based selection for intravenous thrombolysis (IVT) in extended-window acute ischemic stroke (AIS), we performed a systematic review and meta-analysis of randomized controlled trials enrolling adults with acute ischemic stroke treated with imaging-selected IVT beyond 4.5 h from last known well or with unknown onset. Trials using DWI–FLAIR mismatch or CT/MR perfusion selection were included. Outcomes were excellent functional outcome, functional independence, symptomatic intracranial hemorrhage (sICH), parenchymal hematoma, major bleeding, and mortality. Random-effects pairwise meta-analysis and Bucher-type indirect comparison were performed. Eight randomized trials including 2,546 patients were analyzed. Compared with best medical treatment, IVT improved excellent functional outcome (mRS 0–1: RR 1.27, 95% CI 1.14–1.40) and functional independence (mRS 0–2: RR 1.15, 95% CI 1.07–1.23), but increased sICH (RR 5.21, 95% CI 2.25–12.04). In imaging-stratified analyses, functional outcome RRs favored IVT in both perfusion-based and DWI–FLAIR mismatch-selected trials, with wider confidence intervals in the DWI–FLAIR subgroup. Hemorrhagic risk was increased with intravenous thrombolysis in both imaging subgroups, but subgroup interaction testing and a Bucher-type indirect comparison did not detect a statistically significant between-paradigm difference; the indirect comparison re-expresses the subgroup contrast rather than adding independent evidence. In AIS patients not planned for routine endovascular therapy, imaging-selected IVT beyond 4.5 h was associated with improved functional outcomes but increased sICH risk. No definitive superiority or equivalence was established between imaging strategies; imaging choice should be guided by clinical context, time window, EVT eligibility, local workflow, and patient-level factors. This meta-analysis included eight randomized controlled trials involving 2,546 patients and compared imaging-selected intravenous thrombolysis (IVT) with best medical treatment (BMT) beyond 4.5 hours from last known well or with unknown onset. Overall pairwise meta-analysis showed improved excellent functional outcome (mRS 0–1; RR 1.27, 95% CI 1.14–1.40) and functional independence (mRS 0–2; RR 1.15, 95% CI 1.07–1.23) with IVT, with an increased risk of symptomatic intracranial hemorrhage (RR 5.21, 95% CI 2.25–12.04). Imaging-stratified analyses showed treatment effects favoring IVT in both perfusion-based and DWI–FLAIR mismatch-selected trials. Subgroup interaction tests and the Bucher-type indirect comparison did not demonstrate a statistically significant difference between imaging-selection strategies. Abbreviations: IVT, intravenous thrombolysis; BMT, best medical treatment; DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; mRS, modified Rankin Scale; RR, risk ratio; CI, confidence interval; sICH, symptomatic intracranial hemorrhage
1
Across eight randomized trials involving 2,546 patients, imaging-selected intravenous thrombolysis beyond 4.5 hours improved excellent functional outcome and functional independence versus medical treatment.
2
Functional outcomes favored thrombolysis in both perfusion-selected and DWI–FLAIR mismatch-selected trials, although confidence intervals were wider for the DWI–FLAIR subgroup.
3
Intravenous thrombolysis increased symptomatic intracranial hemorrhage risk compared with best medical treatment (RR 5.21, 95% CI 2.25–12.04).
4
Neither imaging strategy showed definitive superiority or equivalence; selection should consider clinical context, treatment timing, EVT eligibility, workflow, and patient-level factors.
5
No statistically significant difference in efficacy or hemorrhagic risk was demonstrated between perfusion-based and DWI–FLAIR mismatch selection strategies.

adults with acute ischemic stroke receiving imaging-selected intravenous thrombolysis in the extended or unknown-onset window

the comparative efficacy and safety of DWI–FLAIR mismatch versus CT/MR perfusion-based selection for extended-window intravenous thrombolysis, including functional and hemorrhagic outcomes

Publication Details
Publication Date
2026-09-18
Journal
Publisher
ISSN
Cited by
0
Access Type
Author Information
Authors
Jagkirat Singh
Victor Hugo Pinheiro Lopes
Marianna Gerardo Hidalgo Santos Jorge Leite
Gustavo Nascimento de Medeiros
Julie de Lima Loiola
Luisa Medeiros Visentini
Ocílio Ribeiro Gonçalves
Amit Bansal
Leonardo Di Cosmo
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%